Associated Papers
Functional Homologous Recombination (HR) Screening Shows the Majority of BRCA1/2-Mutant Breast and Ovarian Cancer Cell Lines Are HR-Proficient.
Meijer TG et al.
Cancers, 2024
38398132 (PubMed )
Supplement: cancers-16-00741-s001.zip › Table_S1-2_WES_results.xlsx › Table_S1
The relative timing of mutations in a breast cancer genome.
Newman S et al.
Plos One, 2013
23762276 (PubMed )
Supplement: pone.0064991.s002.xls › 6._Sequence-level_mutations
The genomic landscapes of human breast and colorectal cancers.
Wood LD et al.
Science (new York, N.y.), 2007
17932254 (PubMed )
Supplement: 1145720s_tables.zip › 1145720tableS3.xls › Both
Select a paper to view details